000 01770 a2200505 4500
005 20250515002302.0
264 0 _c20051115
008 200511s 0 0 eng d
022 _a0021-9746
024 7 _a10.1136/jcp.2004.024919
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFarabegoli, F
245 0 0 _aSuppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma.
_h[electronic resource]
260 _bJournal of clinical pathology
_cOct 2005
300 _a1046-50 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aBiomarkers, Tumor
_xmetabolism
650 0 4 _aBreast Neoplasms
_xmetabolism
650 0 4 _aCell Cycle Proteins
_xmetabolism
650 0 4 _aCell Proliferation
650 0 4 _aCyclin A
_xmetabolism
650 0 4 _aCyclin-Dependent Kinase Inhibitor p27
650 0 4 _aDNA-Binding Proteins
_xgenetics
650 0 4 _aErbB Receptors
_xmetabolism
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIn Situ Hybridization, Fluorescence
650 0 4 _aKi-67 Antigen
_xmetabolism
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Proteins
_xgenetics
650 0 4 _aRepressor Proteins
_xgenetics
650 0 4 _aRetinoblastoma Protein
_xmetabolism
650 0 4 _aSuppressor of Cytokine Signaling Proteins
650 0 4 _aSurvival Rate
650 0 4 _aTrans-Activators
_xgenetics
650 0 4 _aTumor Suppressor Proteins
_xmetabolism
700 1 _aCeccarelli, C
700 1 _aSantini, D
700 1 _aTaffurelli, M
773 0 _tJournal of clinical pathology
_gvol. 58
_gno. 10
_gp. 1046-50
856 4 0 _uhttps://doi.org/10.1136/jcp.2004.024919
_zAvailable from publisher's website
999 _c15820368
_d15820368